PLI Scheme Review Committee Raises Concern Over Delays In Payments
New Delhi: A high-level government committee has raised concern over continued delays in payment to companies in the production-linked incentive (PLI) schemes, Business Standard has learnt. The committee has called…
Gujarat Receives Rs. 18,155 Crore Investment As Part Of VGGS 2023: Dr H G Koshia
Mumbai: Gujarat has received Rs. 18,155 crore investment as part of 167 MoUs signed in the Vibrant Global Gujarat Summit (VGGS) 2023, informed Dr H G Koshia, Gujarat Food and…
Sun Pharma Inks Non-Exclusive License Agreement With Takeda To Introduce Vonoprazan Tablets In India
New Delhi: Sun Pharmaceutical Industries on Friday said it has inked a licensing pact with Takeda Pharmaceutical Company to commercialise a novel gastrointestinal drug in India. The company has entered…
Look-Alike, Sounding Similar Drugs Likely To Face Strict Action
NEW DELHI: Have you ever got confused by similar looking or same sounding medicines? Here is some good news. Drug manufacturers may face strict action by the drug regulatory authority for…
Centre Forms 5-Member Panel To Examine Manufacturing Of Nutraceuticals Within Drug Production Facility
Bengaluru: Union government has now formed a committee to examine the matter of manufacturing of nutraceuticals within the drug manufacturing facility. This follows the implementation of revised Schedule M mandating…
Punjab: 11-Month-Old Given Expired Vaccine At Amritsar’s Private Hospital
Amritsar: Parents of an 11-month-old child held a protest at a private hospital in Amritsar district on Wednesday after they found that an expired vaccine had been administered to their child.…
Expert Panel To Soon Weigh Plan To Use Generics For Prescription Drugs
New Delhi: An expert committee is likely to meet soon to deliberate on a contentious proposal to assess the feasibility of allowing generic substitutions for prescription drugs, said people familiar with…
Illegal Ozempic Shipments Are Coming Into US, Says CBP
Washington: Customs and Border Protection (CBP in the US says it is regularly intercepting shipments of counterfeit and otherwise illegal versions of Novo Nordisk’s diabetes therapy Ozempic, as consumers in…
CBI To Probe Ex-Assistant Drugs Controller Misconduct: High Court
New Delhi: In a significant development, the High Court of Punjab and Haryana has directed the Central Bureau of Investigation (CBI) to take over the investigation of a case involving…
FoPE Raises Concerns Over New Schedule M’s Impact On Cosmetic Manufacturing
New Delhi: The pharmaceutical industry has raised concerns regarding the government’s newly notified schedule M that proposes a blanket ban on manufacture of any other article or product apart from drugs…
